World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease

Overview of attention for article published in Journal of Clinical Gastroenterology, November 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 2 X users
guideline: 3 clinical guideline sources

Readers on

mendeley: 242 Mendeley

So far, Altmetric has seen 3 Guidelines that reference this research output.

Guía GADECCU 2022 para el tratamiento de la colitis ulcerosa. Adaptación y actualización de la Guía GETECCU 2020

Clinical guideline published by Grupo Argentino de Crohn y Colitis Ulcerosa (GADECCU) on 31 Jan 2023

Grupo Argentino de Crohn y Colitis Ulcerosa (GADECCU) is a non-profit scientific association comprising medical professionals focused on Inflammatory Bowel Disease (IBD) in Argentina. It aims to promote research, education, and patient care related to Crohn's disease and ulcerative colitis.

Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in ulcerative colitis and Crohn’s disease

Clinical guideline published by European Society of Pathology (ESP) on 29 Dec 2020

The European Society of Pathology (ESP) is a leading organization dedicated to enhancing pathology practices across Europe. It promotes high-quality diagnostic standards, supports education, and fosters research to improve patient care. ESP also provides guidelines and resources for professionals in the field.

Guía GETECCU 2020 para el tratamiento de la colitis ulcerosa. Elaborada con metodología GRADE

Clinical guideline published by Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) on 01 Aug 2020

The primary objective of GETECCU is to study and research Inflammatory Bowel Disease (IBD) and to seek the standardization of clinical-therapeutic criteria in its diagnosis and treatment.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.